low dose BIBF1120 once daily
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Boehringer Ingelheim
Overview
low dose BIBF1120 once daily is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
low dose BIBF1120 once daily clinical trials
Explore related
Medical disclaimer. This page summarizes research about low dose BIBF1120 once daily for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.